66 related articles for article (PubMed ID: 26062053)
1. VII. Are lymphomas driven by epigenetic lesions?
Boss IW; Melnick AM
Hematol Oncol; 2015 Jun; 33 Suppl 1():42-5. PubMed ID: 26062053
[No Abstract] [Full Text] [Related]
2. Recombination activating gene-expression in lymphoma cell lines and lymphomas.
Knecht H
Blood; 1995 Jul; 86(1):412-4. PubMed ID: 7795253
[No Abstract] [Full Text] [Related]
3. FGF-2 expression and its action in human leukemia and lymphoma cell lines.
Krejci P; Faitova J; Laurell H; Hampl A; Dvorak P
Leukemia; 2003 Apr; 17(4):818-20. PubMed ID: 12682649
[No Abstract] [Full Text] [Related]
4. Common features and differences in the transcriptome of large cell anaplastic lymphoma and classical Hodgkin's lymphoma.
Willenbrock K; Küppers R; Renné C; Brune V; Eckerle S; Weidmann E; Bräuninger A; Hansmann ML
Haematologica; 2006 May; 91(5):596-604. PubMed ID: 16670065
[TBL] [Abstract][Full Text] [Related]
5. [Value of protein 53 expression in lymphoma. Its correlation with genetic mutations].
Echezarreta G; Marcos B; Sanz C; Martínez B; Benítez J; Oliva H; Rivas C
Sangre (Barc); 1997 Oct; 42(5):369-75. PubMed ID: 9424736
[TBL] [Abstract][Full Text] [Related]
6. Can we use epigenetics to prime chemoresistant lymphomas?
Amengual JE
Hematology Am Soc Hematol Educ Program; 2020 Dec; 2020(1):85-94. PubMed ID: 33275728
[TBL] [Abstract][Full Text] [Related]
7. The bcl-2 gene and 14;18 translocation in lymphoproliferative disorders.
Pezzella F; Mason DY
Nouv Rev Fr Hematol (1978); 1990; 32(6):397-9. PubMed ID: 2101872
[TBL] [Abstract][Full Text] [Related]
8. [Molecular abnormalities in lymphomas].
Delsol G
Bull Cancer; 2010 Nov; 97(11):1347-64. PubMed ID: 21084243
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic targeting in lymphoma.
Booth S; Collins G
Br J Haematol; 2021 Jan; 192(1):50-61. PubMed ID: 32609383
[TBL] [Abstract][Full Text] [Related]
10. Protein indexing in leukemias and lymphomas.
Lester EP; Lemkin PF; Lipkin LE
Ann N Y Acad Sci; 1984; 428():158-72. PubMed ID: 6588904
[No Abstract] [Full Text] [Related]
11. Epigenetic silencing of multiple genes in primary CNS lymphoma.
Chu LC; Eberhart CG; Grossman SA; Herman JG
Int J Cancer; 2006 Nov; 119(10):2487-91. PubMed ID: 16858686
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic regulation of the expression of the novel stem cell marker CDCP1 in cancer cells.
Ikeda JI; Morii E; Kimura H; Tomita Y; Takakuwa T; Hasegawa JI; Kim YK; Miyoshi Y; Noguchi S; Nishida T; Aozasa K
J Pathol; 2006 Sep; 210(1):75-84. PubMed ID: 16823897
[TBL] [Abstract][Full Text] [Related]
13. Not proper ROC curves as new tool for the analysis of differentially expressed genes in microarray experiments.
Parodi S; Pistoia V; Muselli M
BMC Bioinformatics; 2008 Oct; 9():410. PubMed ID: 18834513
[TBL] [Abstract][Full Text] [Related]
14. [New diagnostic and therapeutic strategies for aggressive lymphomas].
Trümper L; Glass B; Hartmann F; Pfreundschuh M
Dtsch Med Wochenschr; 2004 Oct; 129(40):2113-7. PubMed ID: 15455303
[No Abstract] [Full Text] [Related]
15. Indolent lymphomas.
Kahl B
Best Pract Res Clin Haematol; 2018 Mar; 31(1):1. PubMed ID: 29452659
[No Abstract] [Full Text] [Related]
16. FK506 restores sensitivity of thymic lymphomas to calcium-mediated apoptosis and the inducible expression of Fas ligand.
Kalas W; Matuszyk J; Ziolo E; Strzadala L
Anticancer Res; 2003; 23(2B):1613-7. PubMed ID: 12820430
[TBL] [Abstract][Full Text] [Related]
17. Is childhood MDS an epigenetic disease?
Flotho C
Leuk Res; 2007 Jun; 31(6):743. PubMed ID: 17169424
[No Abstract] [Full Text] [Related]
18. Deregulated expression of Polycomb-group oncogenes in human malignant lymphomas and epithelial tumors.
Raaphorst FM
Hum Mol Genet; 2005 Apr; 14 Spec No 1():R93-R100. PubMed ID: 15809278
[TBL] [Abstract][Full Text] [Related]
19. [Genetic mutations in malignant lymphoma: the molecular and clinical significances and the application for development of molecular targeting therapeutics].
Tomita A
Rinsho Ketsueki; 2013 Oct; 54(10):1788-98. PubMed ID: 24064830
[No Abstract] [Full Text] [Related]
20. Clinical and pathological features of Burkitt lymphoma showing expression of BCL2--an analysis including gene expression in formalin-fixed paraffin-embedded tissue.
Masqué-Soler N; Szczepanowski M; Kohler CW; Aukema SM; Nagel I; Richter J; Siebert R; Spang R; Burkhardt B; Klapper W
Br J Haematol; 2015 Nov; 171(4):501-8. PubMed ID: 26218299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
